FeesSafety
Pluang+

Fiat-to-crypto buying now available in Telegram's Walt app via Alchemy Pay integration

Protocol Fundamentals
03 Nov 2026, 11:26 WIB
Tokenpost
View Source
Neutral
Fiat-to-crypto buying now available in Telegram's Walt app via Alchemy Pay integration

Alchemy Pay has integrated its fiat-to-crypto service into Walt, a digital-asset app within Telegram, allowing users to purchase supported cryptocurrencies using traditional currency. The app directs users to payment providers like Alchemy Pay or Mercuryo to complete transactions, with options varying by location and provider terms. Walt supports buying 14 assets and selling 10 assets for bank card funds, though availability depends on the payment provider. This integration expands access to crypto purchases through familiar payment methods like Visa, Mastercard, and local bank transfers, with user verification required for transactions.

Alchemy Pay's integration with Walt app on Telegram offers new fiat-to-crypto purchase options. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Nov 03, 2026 15:41 WIB: out of 50 major cryptocurrencies, only 7 rose while 42 fell. Among them, AAVE is priced at Rp2.306.640 with a 1-day change of -4.94% and a typical hold time of 106 days, contrasting with BAT at Rp2.278, down 4.92% but favored by buyers at 95%, and COTI at Rp177 with a 4.37% drop and a more balanced sell/buy activity.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
45 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
45 minutes ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
45 minutes ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
1 hour ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App